Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in AF patients undergoing cardioversion
NCT07568964Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- May 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Ain Shams University. Primary endpoint: Atrial Fibrillation Recurrence at 7 days. Planned start May 2026; status: not yet recruiting.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07568964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568964.